Understanding the burden of pneumococcal disease in adults.
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsMethodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectivenessEpidemiology, virulence factors and management of the pneumococcusThe role of vaccination in preventing pneumococcal disease in adultsOverview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study.The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature reviewLong-term mortality after community-acquired pneumonia--impacts of diabetes and newly discovered hyperglycaemia: a prospective, observational cohort study.Development of Streptococcus pneumoniae Vaccines Using Live VectorsCeftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010.Disease isolates of Streptococcus pseudopneumoniae and non-typeable S. pneumoniae presumptively identified as atypical S. pneumoniae in SpainIdentification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013.Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance.Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A.Estimated hospitalization rate for diseases attributable to Streptococcus pneumoniae in the Veneto region of north-east ItalyRisk factors for community-acquired pneumonia in adults in Europe: a literature review.The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the hostVaccination in the elderly: what can be recommended?Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development.Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy.Pneumococcal conjugate vaccine use in adults.Location in the spleen dictates the function of murine neutrophils.Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.In vitro activity of bioactive extracts from rare actinomycetes against multi-drug resistant Streptococcus pneumoniae.Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy.Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae.Seasonality of pathogens causing community-acquired pneumonia.Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons.Use of an automated PCR assay, the GenomEra S. pneumoniae, for rapid detection of Streptococcus pneumoniae in blood cultures.Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival.Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.Advances in pneumococcal antibiotic resistance.Pneumococcal infection--low awareness as a potential barrier to vaccination: results of a European study.Evidence for Human Streptococcus pneumoniae in wild and captive chimpanzees: A potential threat to wild populations.Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of S. Pneumoniae.Health related quality of life in patients with community-acquired pneumococcal pneumonia in France.
P2860
Q26744448-A5A02D4A-1185-402B-B789-2193713E8B61Q26770693-A649EF7B-CFA1-42D2-B4FA-0F4A1F2B4DD4Q28078832-25EB9B4A-10A4-4702-AFF6-9A90F317A379Q28396749-642E162C-698E-416B-847F-045418E2CF94Q30358199-86704BEF-DD50-42DE-8C2E-CC2144746163Q33581932-D9E6E3B8-43CB-43F7-BF36-4A35F38A806FQ33701151-FB42C5E4-1B02-4342-ADC3-67762C840A92Q34144880-9BB79050-9DFA-4AFA-B5FB-32BE9078E821Q34316015-B0CF5BEA-945A-4649-99AA-4DD51BE21A6AQ34417616-5039FFF1-31C8-4539-9D30-A0FF317F14D9Q34599946-0980AF33-5F5D-41E8-87E4-6C46B378B828Q34876231-925CD34C-9F90-4107-98A9-639438F54FCCQ35737956-8BA04A91-1995-4758-BD9E-E70FC1C0B0D7Q36104773-13A884F4-6359-42AD-961E-BE8D1C6FB61FQ36184650-93D5BA56-B64E-469A-AAB7-3BA3BC3E6833Q36409520-DDBEC8BC-A5A9-4D43-8145-EAC917028922Q36800391-4EDB63C3-2469-4620-AFFB-3132C21799C2Q37267627-3AC5878A-3493-4FC4-B6F7-2DD270C323BFQ38143425-4E09F43A-CB85-4942-83D0-5A7493167D57Q38220158-8EA74543-372A-4D7C-99E0-12C9CC9DEAE3Q38255618-46A404EE-5357-4114-9A75-454EABAEED14Q38622377-D77C1A43-E84F-41F5-A71E-D44518B9638AQ38637902-ED828C3A-205C-4FE5-9ED3-251A187B1D80Q38664425-7A7DCDBD-6E1F-48BE-AE36-54675908CF9AQ38829708-325C1411-3FFE-45DC-ACD2-2A199EF84A61Q39041235-70F96711-63AC-4ED1-BF1D-DB0D147FE262Q39526130-D507870F-B4B0-4816-988A-474B156E9C72Q39836338-254E5F12-EB8B-4CE4-B5E0-D06D3887B729Q40074304-C1D51CCB-8E19-4D3C-8516-CF5B9AF2E02CQ40244992-E6B611E5-AF09-4153-8995-7590C8BAA7DAQ40369631-18CAA99A-3381-42DC-86DE-900402BE23EBQ40438234-C2E2A2F3-4298-465C-9DE1-7E1B6A7F1497Q41114576-9B971A28-6811-4B63-B977-5DB782BF9F29Q41480967-B143AB68-015A-407F-80C2-1B9E50804014Q42203694-940E6C9D-EC8C-4FC8-8265-814F84999F33Q42243746-E7A39618-330D-44C2-9D97-CAC7AFA15B9FQ44400653-5BB41689-449B-4189-B737-6B329CBFD7D8Q46202735-1824906A-2D09-4700-8F36-CC301FD669A7Q47269510-B61A97CA-E2AD-452E-A30D-5D9C14DB980EQ48113484-436024F5-E642-4517-B0AE-7DD48DF71F7F
P2860
Understanding the burden of pneumococcal disease in adults.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Understanding the burden of pneumococcal disease in adults.
@ast
Understanding the burden of pneumococcal disease in adults.
@en
Understanding the burden of pneumococcal disease in adults.
@nl
type
label
Understanding the burden of pneumococcal disease in adults.
@ast
Understanding the burden of pneumococcal disease in adults.
@en
Understanding the burden of pneumococcal disease in adults.
@nl
prefLabel
Understanding the burden of pneumococcal disease in adults.
@ast
Understanding the burden of pneumococcal disease in adults.
@en
Understanding the burden of pneumococcal disease in adults.
@nl
P50
P1476
Understanding the burden of pneumococcal disease in adults.
@en
P2093
P356
10.1111/J.1469-0691.2012.03937.X
P478
18 Suppl 5
P577
2012-08-06T00:00:00Z